title: Long-term results after transcatheter aortic valve implantation: what do we know today?
abstract: Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.
authors: Y
authors: Y
authors: Elhmidi
authors: S
authors: S
authors: Bleiziffer
authors: N
authors: N
authors: Piazza
authors: B
authors: B
authors: Voss
authors: M
authors: M
authors: Krane
authors: M-A
authors: MA
authors: Deutsch
authors: German Heart Centre Munich, Lazarettestrasse 36, 80636, Munich, Germany. elhmidi@dhm.mhn.de.
authors: R
authors: R
authors: Lange
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000401:mortality / Q000601:surgery*; D006328:Cardiac Catheterization / Q000379:methods* / Q000401:mortality; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D006439:Hemodynamics; D006801:Humans; D015996:Survival Rate; D016896:Treatment Outcome